CMS Announces New Flexibilities For Coverage of Medicare Part B Drugs Administered in a Home Setting

On March 30, 2020, CMS announced that, in light of the coronavirus pandemic, it would be waiving several Medicare reimbursement regulations to permit reimbursement to providers treating patients remotely, consistent with current social distancing guidelines, and would be allowing providers to receive reimbursement for Medicare Part B drugs that are administered to a patient in his or her home. Although there is no general rule that prohibits Medicare Part B coverage for drugs that are administered in a patient’s home, many prescription drugs are typically covered by Part B only when administered in an office or clinic setting.